PTC Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PTC Therapeutics, Inc. (PTCT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.11 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-30
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.69M shares, a 196.95% increase year-over-year.
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 3.60M shares, a 72.85% decline year-over-year.
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 13.26M shares, a 15.81% decline year-over-year.
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 15.75M shares, a 10.40% increase year-over-year.
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.12M shares, a 82.35% decline from fiscal 2024.
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.01M shares, a 3.66% decline from fiscal 2023.
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.47M shares, a 725.76% increase from fiscal 2022.
- PTC Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.51M shares, a 87.72% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.11M shares 10-Q · filed 2026-07-30 | ||||||
| 2026-03-31 | 10.69M shares 10-Q · filed 2026-05-07 | ||||||
| 2025-12-31 | 2.12M shares 10-K · filed 2026-02-19 | ||||||
| 2025-09-30 | 6.07M shares 10-Q · filed 2025-11-04 | ||||||
| 2025-06-30 | 3.58M shares 10-Q · filed 2026-07-30 | 6.30M shares 10-Q · filed 2025-08-07 | |||||
| 2025-03-31 | 3.60M shares 10-Q · filed 2026-05-07 | 6.36M shares 10-Q · filed 2025-05-06 | |||||
| 2024-12-31 | 12.01M shares 10-K · filed 2026-02-19 | 1.18M shares 10-K · filed 2025-02-27 | |||||
| 2024-09-30 | 12.77M shares 10-Q · filed 2025-11-04 | ||||||
| 2024-06-30 | 12.88M shares 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | 13.26M shares 10-Q · filed 2025-05-06 | ||||||
| 2023-12-31 | 12.47M shares 10-K · filed 2026-02-19 | ||||||
| 2023-09-30 | 14.85M shares 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | 15.29M shares 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | 15.75M shares 10-Q · filed 2024-04-25 | ||||||
| 2022-12-31 | 1.51M shares 10-K · filed 2025-02-27 | 14.02M shares 10-K · filed 2023-02-21 | |||||
| 2022-09-30 | 13.97M shares 10-Q · filed 2023-10-26 | ||||||
| 2022-06-30 | 14.33M shares 10-Q · filed 2023-08-03 | ||||||
| 2022-03-31 | 14.27M shares 10-Q · filed 2023-04-27 | ||||||
| 2021-12-31 | 12.29M shares 10-K · filed 2024-02-29 | ||||||
| 2021-09-30 | 12.42M shares 10-Q · filed 2022-10-27 | ||||||
| 2021-06-30 | 12.56M shares 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | 12.48M shares 10-Q · filed 2022-05-03 | ||||||
| 2020-12-31 | 10.65M shares 10-K · filed 2023-02-21 | ||||||
| 2020-09-30 | 12.49M shares 10-Q · filed 2021-10-28 | ||||||
| 2020-06-30 | 12.89M shares 10-Q · filed 2021-07-29 | ||||||
| 2020-03-31 | 13.60M shares 10-Q · filed 2021-05-04 | ||||||
| 2019-12-31 | 11.69M shares 10-K · filed 2022-02-22 | 11.70M shares 10-K · filed 2020-03-02 | |||||
| 2019-09-30 | 11.39M shares 10-Q · filed 2020-10-29 | ||||||
| 2019-06-30 | 11.52M shares 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | 11.51M shares 10-Q · filed 2020-04-30 | ||||||
| 2018-12-31 | 9.11M shares 10-K · filed 2021-02-25 | ||||||
| 2018-09-30 | 10.13M shares 10-Q · filed 2019-10-30 | ||||||
| 2018-06-30 | 8.75M shares 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | 8.79M shares 10-Q · filed 2019-05-02 | ||||||
| 2017-12-31 | 6.84M shares 10-K · filed 2020-03-02 | ||||||
| 2017-09-30 | 7.02M shares 10-Q · filed 2018-11-05 | ||||||
| 2017-06-30 | 7.55M shares 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | 7.57M shares 10-Q · filed 2018-05-09 | ||||||
| 2016-12-31 | 6.13M shares 10-K · filed 2019-03-01 | ||||||
| 2016-09-30 | 6.10M shares 10-Q · filed 2017-11-02 | ||||||
| 2016-06-30 | 6.24M shares 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | 6.49M shares 10-Q · filed 2017-05-08 | ||||||
| 2015-12-31 | 5.17M shares 10-K · filed 2018-03-06 | ||||||
| 2015-09-30 | 5.14M shares 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | 5.02M shares 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | 4.99M shares 10-Q · filed 2016-05-05 | ||||||
| 2014-12-31 | 4.15M shares 10-K · filed 2017-03-16 | ||||||
| 2014-09-30 | 4.17M shares 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | 3.91M shares 10-Q · filed 2015-07-31 | ||||||
| 2014-03-31 | 3.88M shares 10-Q · filed 2015-05-05 | ||||||
| 2013-12-31 | 3.21M shares 10-K · filed 2016-02-29 | 600.00K shares 10-K · filed 2015-03-02 | |||||
| 2013-09-30 | 3.10M shares 10-Q · filed 2014-11-06 | ||||||
| 2013-06-30 | 3.18M shares 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | 781.97K shares 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | 1.30M shares 10-K · filed 2015-03-02 | 600.00K shares 10-K · filed 2014-03-06 | |||||
| 2012-09-30 | 44.22K shares 10-Q · filed 2013-11-14 | ||||||
| 2011-12-31 | 1.30M shares 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |